University of California San Francisco

Publications

  1. An integrated multi-omics biomarker approach using molecular profiling and microRNAs for evaluation of pancreatic cyst fluid.
    Maher MH, Treekitkarnmongkol W, Ghatak S, Dai J, Liu S, Nguyen T, Duose DY, Kim MP, Hu TY, Hurd MW, Paris PL, Kirkwood KS, Maitra A, Luthra R, Sen S, Roy-Chowdhuri S
    Cancer Cytopathol. 2025 Apr; 133(4):e70008.; 
    PubMed
  2. Robotic-assisted trans-mesocolic side-to-side duodenojejunostomy for palliative management of malignant distal duodenal obstruction.
    Yin H, Sharma D, Wang JJ, Ganjouei AA, Kouanda A, Hirose K, Nakakura E, Kirkwood K, Corvera C, Alseidi A, Adam MA
    Chin Clin Oncol. 2025 Feb; 14(1):5.; 
    PubMed
  3. ASO Visual Abstract: Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma.
    Wong P, Pollini T, Adam MA, Alseidi A, Corvera CU, Hirose K, Kirkwood KS, Nakakura EK, Thornblade L, Maker AV
    Ann Surg Oncol. 2025 Jan; 32(1):536.; 
    PubMed
  4. Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC).
    Yin H, Romero-Hernandez F, Ganjouei AA, Wang JJ, Brown A, Hirose K, Maker AV, Nakakura E, Corvera C, Kirkwood KS, Wilhelm A, Peng JS, Alseidi A, Adam MA
    Curr Oncol. 2024 08 28; 31(9):5008-5020.; 
    PubMed
  5. Graft choice in pancreatectomy with vascular resection: equivalent safety in selected patients.
    Hoffman D, Ganjouei AA, Hernandez FR, Ifuku K, Miller P, Glencer A, Corvera C, Kirkwood K, Alseidi A, Adam M, Maker A, Hirose K, Hirose R, Nakakura EK
    J Gastrointest Surg. 2024 Nov; 28(11):1799-1804.; 
    PubMed
  6. ASO Visual Abstract: Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer.
    Miller PN, Romero-Hernandez F, Calthorpe L, Wang JJ, Kim SS, Corvera CU, Hirose K, Kirkwood KS, Hirose R, Maker AV, Alseidi AA, Adam MA, Kim GE, Tempero MA, Ko AH, Nakakura EK
    PubMed
  7. Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma.
    Wong P, Pollini T, Adam MA, Alseidi A, Corvera CU, Hirose K, Kirkwood KS, Nakakura EK, Thornblade L, Maker AV
    Ann Surg Oncol. 2024 Nov; 31(12):8276-8286.; 
    PubMed
  8. Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer.
    Miller PN, Romero-Hernandez F, Calthorpe L, Wang JJ, Kim SS, Corvera CU, Hirose K, Kirkwood KS, Hirose R, Maker AV, Alseidi AA, Adam MA, Kim GE, Tempero MA, Ko AH, Nakakura EK
    Ann Surg Oncol. 2024 Sep; 31(9):6147-6156.; 
    PubMed
  9. National practice patterns in the use of endoscopic ultrasound biopsy for resectable Pancreatic Neuroendocrine Tumors: Insights into the role of DOTATATE PET/CT in diagnosis.
    Casey M, Brown A, Romero-Hernandez F, Wang JJ, Ganjouei AA, Tozzi F, Rashidian N, Kirkwood K, Corvera C, Nakakura E, Alseidi A, Adam M
    Am J Surg. 2024 Sep; 235:115779.; 
    PubMed
  10. A Novel Machine Learning Approach to Predict Textbook Outcome in Colectomy.
    Ashraf Ganjouei A, Romero-Hernandez F, Conroy PC, Miller PN, Calthorpe L, Wang JJ, Lin JJ, Feng J, Kirkwood KS, Alseidi A, Sarin A, Adam MA
    Dis Colon Rectum. 2024 Feb 01; 67(2):322-332.; 
    PubMed
  11. Addressing the unmet clinical need for low-volume assays in early diagnosis of pancreatic cancer.
    Sheik DA, Byers K, Thomas M, Rajesh UC, Ifuku K, Kirkwood K, Al-Haddad M, Craik CS, Davisson VJ
    Front Gastroenterol (Lausanne). 2023; 2.; 
    PubMed
  12. A Machine Learning Approach to Predict Postoperative Pancreatic Fistula After Pancreaticoduodenectomy Using Only Preoperatively Known Data.
    Ashraf Ganjouei A, Romero-Hernandez F, Wang JJ, Casey M, Frye W, Hoffman D, Hirose K, Nakakura E, Corvera C, Maker AV, Kirkwood KS, Alseidi A, Adam MA
    Ann Surg Oncol. 2023 Nov; 30(12):7738-7747.; 
    PubMed
  13. ASO Visual Abstract: National Practice Patterns in Malignant Peritoneal Mesothelioma-Updates in Management and Survival.
    Calthorpe L, Romero-Hernandez F, Casey M, Nunez M, Conroy PC, Hirose K, Kim A, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA
    Ann Surg Oncol. 2023 Aug; 30(8):5131.; 
    PubMed
  14. National Practice Patterns in Malignant Peritoneal Mesothelioma: Updates in Management and Survival.
    Calthorpe L, Romero-Hernandez F, Casey M, Nunez M, Conroy PC, Hirose K, Kim A, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA
    Ann Surg Oncol. 2023 Aug; 30(8):5119-5129.; 
    PubMed
  15. Robotic-assisted approach for complex cholecystectomies.
    Zhu G, Ifuku KA, Kirkwood KS
    Mini Invasive Surg. 2023; 7.; 
    PubMed
  16. Hypertension Requiring Medication Use: a Silent Predictor of Poor Outcomes After Pancreaticoduodenectomy.
    Lin JJ, Conroy PC, Romero-Hernandez F, Yilma M, Feng J, Hirose K, Nakakura E, Maker AV, Corvera C, Kirkwood K, Alseidi A, Adam MA
    J Gastrointest Surg. 2023 02; 27(2):328-336.; 
    PubMed
  17. Contemporary Trends in Malignant Peritoneal Mesothelioma: Incidence and Survival in the United States.
    Calthorpe L, Romero-Hernandez F, Miller P, Conroy PC, Hirose K, Kim A, Kirkwood K, Nakakura E, Corvera C, Maker AV, Alseidi A, Adam MA
    Cancers (Basel). 2022 Dec 30; 15(1).; 
    PubMed
  18. Implementation, evaluation, and modification of a near-peer learning group in graduate surgical education.
    Conroy PC, Mohamedaly S, Karimzada M, Brian R, Im C, Hernandez S, Roman S, Hirose K, Mukhtar R, Kirkwood K, O'Sullivan P, Alseidi A
    Am J Surg. 2023 03; 225(3):591-592.; 
    PubMed
  19. Hand-Assisted Versus Pure Minimally-Invasive Distal Pancreatectomy: Is There a Downside to Lending a Hand?
    Miller PN, Romero-Hernandez F, Conroy P, Calthorpe L, Yilma M, Mohamedaly S, Kelly YM, Feng J, Hirose K, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA
    World J Surg. 2023 03; 47(3):750-758.; 
    PubMed
  20. Minimally Invasive Distal Pancreatectomy Techniques: A Contemporary Analysis Exploring Trends, Similarities, and Differences to Open Surgery.
    Romero-Hernandez F, Mohamedaly S, Miller P, Rodriguez N, Calthorpe L, Conroy PC, Ganjouei AA, Hirose K, Maker AV, Nakakura E, Corvera C, Kirkwood KS, Alseidi A, Adam MA
    Cancers (Basel). 2022 Nov 16; 14(22).; 
    PubMed
  21. Accurate Identification of Mucinous Pancreatic Cystic Lesions Using Small-Volume Analytes.
    Caiazza F, Conroy PC, Ivry SL, York T, Lin J, Hernandez S, Hoffmann TJ, Francis SS, Park WG, Yip-Schneider MT, Schmidt CM, Brand R, Craik CS, Kirkwood K
    J Surg Res. 2023 04; 284:322-331.; 
    PubMed
  22. Translation of a Protease Turnover Assay for Clinical Discrimination of Mucinous Pancreatic Cysts.
    Suresh V, Byers K, Rajesh UC, Caiazza F, Zhu G, Craik CS, Kirkwood K, Davisson VJ, Sheik DA
    Diagnostics (Basel). 2022 May 28; 12(6).; 
    PubMed
  23. Assessing the role of robotic proctectomy in obese patients: a contemporary NSQIP analysis.
    Glencer AC, Lin JA, Trang K, Greenberg A, Kirkwood KS, Adam MA, Sarin A
    J Robot Surg. 2022 Dec; 16(6):1391-1399.; 
    PubMed
  24. ASO Visual Abstract: Determining Hospital Volume Threshold for the Safety of Minimally Invasive Pancreaticoduodenectomy: A Contemporary Cutpoint Analysis.
    Conroy PC, Calthorpe L, Lin JA, Mohamedaly S, Kim A, Hirose K, Nakakura E, Corvera C, Sosa JA, Sarin A, Kirkwood KS, Alseidi A, Adam MA
    Ann Surg Oncol. 2022 Jan 15.; 
    PubMed
  25. Determining Hospital Volume Threshold for Safety of Minimally Invasive Pancreaticoduodenectomy: A Contemporary Cutpoint Analysis.
    Conroy PC, Calthorpe L, Lin JA, Mohamedaly S, Kim A, Hirose K, Nakakura E, Corvera C, Sosa JA, Sarin A, Kirkwood KS, Alseidi A, Adam MA
    Ann Surg Oncol. 2022 Mar; 29(3):1566-1574.; 
    PubMed
  26. The surgical resident experience in serious illness communication: A qualitative needs assessment with proposed solutions.
    Lin JA, Im CJ, O'Sullivan P, Kirkwood KS, Cook AC
    Am J Surg. 2021 Dec; 222(6):1126-1130.; 
    PubMed
  27. Burden of Ionizing Radiation in the Diagnosis and Management of Necrotizing Pancreatitis.
    Thiruvengadam NR, Miranda J, Kim C, Behr S, Corvera C, Dai SC, Kirkwood K, Harris HW, Hirose K, Nakakura E, Ostroff JW, Kochman ML, Arain MA
    Clin Transl Gastroenterol. 2021 04 27; 12(5):e00347.; 
    PubMed
  28. Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer.
    Dittmar RL, Liu S, Tai MC, Rajapakshe K, Huang Y, Longton G, DeCapite C, Hurd MW, Paris PL, Kirkwood KS, Coarfa C, Maitra A, Brand RE, Killary AM, Sen S
    Cancer Prev Res (Phila). 2021 07; 14(7):729-740.; 
    PubMed
  29. Cost-effectiveness of consensus guideline based management of pancreatic cysts: The sensitivity and specificity required for guidelines to be cost-effective.
    Sharib J, Esserman L, Koay EJ, Maitra A, Shen Y, Kirkwood KS, Ozanne EM
    Surgery. 2020 10; 168(4):601-609.; 
    PubMed
  30. Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer.
    Moroz A, Wang YH, Sharib JM, Wei J, Zhao N, Huang Y, Chen Z, Martinko AJ, Zhuo J, Lim SA, Zhang LH, Seo Y, Carlin S, Leung KK, Collisson EA, Kirkwood KS, Wells JA, Evans MJ
    Clin Cancer Res. 2020 07 15; 26(14):3608-3615.; 
    PubMed
  31. Ampullary stenosis and choledocholithiasis post Roux-En-Y gastric bypass: challenges of biliary access and intervention.
    Wisneski AD, Carter J, Nakakura EK, Posselt A, Rogers SJ, Cello JP, Arain M, Kirkwood KS, Hirose K, Stewart L, Corvera CU
    HPB (Oxford). 2020 10; 22(10):1496-1503.; 
    PubMed
  32. The lysosomal aminopeptidase tripeptidyl peptidase 1 displays increased activity in malignant pancreatic cysts.
    Ivry SL, Knudsen GM, Caiazza F, Sharib JM, Jaradeh K, Ravalin M, O'Donoghue AJ, Kirkwood KS, Craik CS
    Biol Chem. 2019 11 26; 400(12):1629-1638.; 
    PubMed
  33. Abdominal Imaging of Pancreatic Cysts and Cyst-Associated Pancreatic Cancer in BRCA1/2 Mutation Carriers: A Retrospective Cross-Sectional Study.
    Cao CX, Sharib JM, Blanco AM, Goldberg D, Bracci P, Mukhtar RA, Esserman LJ, Kirkwood KS
    J Am Coll Surg. 2020 01; 230(1):53-63.e1.; 
    PubMed
  34. Comparison of Tumor Regression Grading of Residual Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Chemotherapy Without Radiation: Would Fewer Tier-Stratification Be Favorable Toward Standardization?
    Kim SS, Ko AH, Nakakura EK, Wang ZJ, Corvera CU, Harris HW, Kirkwood KS, Hirose R, Tempero MA, Kim GE
    Am J Surg Pathol. 2019 03; 43(3):334-340.; 
    PubMed
  35. Managing Refractory Postoperative Fistulas as Chronic Wounds Using Video-Assisted Hydrodebridement (VAHD).
    Changala M, Laberge J, Kerlan R, Taylor A, Arain M, Kirkwood K
    J Gastrointest Surg. 2019 03; 23(3):608-612.; 
    PubMed
  36. Surgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making?
    Sharib JM, Fonseca AL, Swords DS, Jaradeh K, Bracci PM, Firpo MA, Hatcher S, Scaife CL, Wang H, Kim GE, Mulvihill SJ, Maitra A, Koay EJ, Kirkwood KS
    Surgery. 2018 12; 164(6):1178-1184.; 
    PubMed
  37. Intraductal Papillary Mucinous Neoplasms of the Pancreas: Current Understanding and Future Directions for Stratification of Malignancy Risk.
    Fonseca AL, Kirkwood K, Kim MP, Maitra A, Koay EJ
    Pancreas. 2018 03; 47(3):272-279.; 
    PubMed
  38. Gangrenous cholecystitis: innovative laparoscopic techniques to facilitate subtotal fenestrating cholecystectomy when a critical view of safety cannot be achieved.
    Kirkwood R, Damon L, Wang J, Hong E, Kirkwood K
    Surg Endosc. 2017 12; 31(12):5258-5266.; 
    PubMed
  39. Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts.
    Ivry SL, Sharib JM, Dominguez DA, Roy N, Hatcher SE, Yip-Schneider MT, Schmidt CM, Brand RE, Park WG, Hebrok M, Kim GE, O'Donoghue AJ, Kirkwood KS, Craik CS
    Clin Cancer Res. 2017 Aug 15; 23(16):4865-4874.; 
    PubMed
  40. Early and accurate diagnosis of pancreatic cancer?
    Sharib J, Kirkwood K
    Oncotarget. 2016 12 27; 7(52):85676-85677.; 
    PubMed
  41. Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?
    Kim SS, Nakakura EK, Wang ZJ, Kim GE, Corvera CU, Harris HW, Kirkwood KS, Hirose R, Tempero MA, Ko AH
    J Surg Oncol. 2016 Oct; 114(5):587-596.; 
    PubMed
  42. Next generation sequencing of pancreatic cyst fluid microRNAs from low grade-benign and high grade-invasive lesions.
    Wang J, Paris PL, Chen J, Ngo V, Yao H, Frazier ML, Killary AM, Liu CG, Liang H, Mathy C, Bondada S, Kirkwood K, Sen S
    Cancer Lett. 2015 Jan 28; 356(2 Pt B):404-9.; 
    PubMed
  43. Serine proteases and protease-activated receptor 2 mediate the proinflammatory and algesic actions of diverse stimulants.
    Cattaruzza F, Amadesi S, Carlsson JF, Murphy JE, Lyo V, Kirkwood K, Cottrell GS, Bogyo M, Knecht W, Bunnett NW
    Br J Pharmacol. 2014 Aug; 171(16):3814-26.; 
    PubMed
  44. Transient receptor potential ankyrin 1 mediates chronic pancreatitis pain in mice.
    Cattaruzza F, Johnson C, Leggit A, Grady E, Schenk AK, Cevikbas F, Cedron W, Bondada S, Kirkwood R, Malone B, Steinhoff M, Bunnett N, Kirkwood KS
    Am J Physiol Gastrointest Liver Physiol. 2013 Jun 01; 304(11):G1002-12.; 
    PubMed
  45. Informed consent for innovative surgery: a survey of patients and surgeons.
    Lee Char SJ, Hills NK, Lo B, Kirkwood KS
    Surgery. 2013 Apr; 153(4):473-80.; 
    PubMed
  46. Active cathepsins B, L, and S in murine and human pancreatitis.
    Lyo V, Cattaruzza F, Kim TN, Walker AW, Paulick M, Cox D, Cloyd J, Buxbaum J, Ostroff J, Bogyo M, Grady EF, Bunnett NW, Kirkwood KS
    Am J Physiol Gastrointest Liver Physiol. 2012 Oct 15; 303(8):G894-903.; 
    PubMed
  47. Ethical management of conflict of interest: proposed standards for academic surgical societies.
    Minter RM, Angelos P, Coimbra R, Dale P, de Vera ME, Hardacre J, Hawkins W, Kirkwood K, Matthews JB, McLoughlin J, Peralta E, Schmidt M, Zhou W, Schwarze ML
    J Am Coll Surg. 2011 Nov; 213(5):677-82.; 
    PubMed
  48. Serine proteases mediate inflammatory pain in acute pancreatitis.
    Ceppa EP, Lyo V, Grady EF, Knecht W, Grahn S, Peterson A, Bunnett NW, Kirkwood KS, Cattaruzza F
    Am J Physiol Gastrointest Liver Physiol. 2011 Jun; 300(6):G1033-42.; 
    PubMed
  49. Transient receptor potential ion channels V4 and A1 contribute to pancreatitis pain in mice.
    Ceppa E, Cattaruzza F, Lyo V, Amadesi S, Pelayo JC, Poole DP, Vaksman N, Liedtke W, Cohen DM, Grady EF, Bunnett NW, Kirkwood KS
    Am J Physiol Gastrointest Liver Physiol. 2010 Sep; 299(3):G556-71.; 
    PubMed
  50. Technique for placement of lumboperitoneal catheters using a combined laparoscopic procedure with the Seldinger micropuncture technique.
    Maa J, Carter JT, Kirkwood KS, Gosnell JE, Wang V, McDermott MW
    J Am Coll Surg. 2008 Jul; 207(1):e5-7.; 
    PubMed
  51. MUC5AC, a gel-forming mucin accumulating in gallstone disease, is overproduced via an epidermal growth factor receptor pathway in the human gallbladder.
    Finzi L, Barbu V, Burgel PR, Mergey M, Kirkwood KS, Wick EC, Scoazec JY, Peschaud F, Paye F, Nadel JA, Housset C
    Am J Pathol. 2006 Dec; 169(6):2031-41.; 
    PubMed
  52. Trends in laparoscopic splenectomy for massive splenomegaly.
    Grahn SW, Alvarez J, Kirkwood K
    Arch Surg. 2006 Aug; 141(8):755-61; discussion 761-2.; 
    PubMed
  53. Calcitonin gene-related peptide partially mediates nociception in acute experimental pancreatitis.
    Wick EC, Pikios S, Grady EF, Kirkwood KS
    Surgery. 2006 Feb; 139(2):197-201.; 
    PubMed
  54. Transient receptor potential vanilloid 1, calcitonin gene-related peptide, and substance P mediate nociception in acute pancreatitis.
    Wick EC, Hoge SG, Grahn SW, Kim E, Divino LA, Grady EF, Bunnett NW, Kirkwood KS
    Am J Physiol Gastrointest Liver Physiol. 2006 May; 290(5):G959-69.; 
    PubMed
  55. Neutral endopeptidase determines the severity of pancreatitis-associated lung injury.
    Day AL, Wick E, Jordan TH, Jaffray CE, Bunnett NW, Grady EF, Kirkwood KS
    J Surg Res. 2005 Sep; 128(1):21-7.; 
    PubMed
  56. Transient receptor potential vanilloid (TRPV-1) promotes neurogenic inflammation in the pancreas via activation of the neurokinin-1 receptor (NK-1R).
    Hutter MM, Wick EC, Day AL, Maa J, Zerega EC, Richmond AC, Jordan TH, Grady EF, Mulvihill SJ, Bunnett NW, Kirkwood KS
    Pancreas. 2005 Apr; 30(3):260-5.; 
    PubMed
  57. Medical versus surgical management of biliary tract disease in pregnancy.
    Lu EJ, Curet MJ, El-Sayed YY, Kirkwood KS
    Am J Surg. 2004 Dec; 188(6):755-9.; 
    PubMed
  58. Pancreatic resection in the elderly.
    Lightner AM, Glasgow RE, Jordan TH, Krassner AD, Way LW, Mulvihill SJ, Kirkwood KS
    J Am Coll Surg. 2004 May; 198(5):697-706.; 
    PubMed
  59. Activation of nociceptive neurons in T9 and T10 in cerulein pancreatitis.
    Kim EH, Hoge SG, Lightner AM, Grady EF, Coelho AM, Kirkwood KS
    J Surg Res. 2004 Apr; 117(2):195-201.; 
    PubMed
  60. SIR 2003 film panel case 5: massive hemorrhage from portal vein disruption.
    Kerlan RK, LaBerge JM, Wilson MW, Gordon RL, Kirkwood K, Sawhney R
    J Vasc Interv Radiol. 2003 Jun; 14(6):797-802.; 
    PubMed
  61. Lovastatin alters biliary lipid composition and dissolves gallstones: a long-term study in prairie dogs.
    Abedin MZ, Narins SC, Park EH, Smith PR, Kirkwood KS
    Dig Dis Sci. 2002 Oct; 47(10):2192-210.; 
    PubMed
  62. Recombinant human neutral endopeptidase ameliorates pancreatic elastase-induced lung injury.
    Lightner AM, Jordan TH, Bunnett NW, Grady EF, Kirkwood KS
    Surgery. 2002 Aug; 132(2):193-9.; 
    PubMed
  63. Pathophysiology of gallstone pancreatitis.
    Lightner AM, Kirkwood KS
    Front Biosci. 2001 Oct 01; 6:E66-76.; 
    PubMed
  64. Deletion of neutral endopeptidase exacerbates intestinal inflammation induced by Clostridium difficile toxin A.
    Kirkwood KS, Bunnett NW, Maa J, Castagliolo I, Liu B, Gerard N, Zacks J, Pothoulakis C, Grady EF
    Am J Physiol Gastrointest Liver Physiol. 2001 Aug; 281(2):G544-51.; 
    PubMed
  65. NK-1 receptor desensitization and neutral endopeptidase terminate SP-induced pancreatic plasma extravasation.
    Maa J, Grady EF, Kim EH, Yoshimi SK, Hutter MM, Bunnett NW, Kirkwood KS
    Am J Physiol Gastrointest Liver Physiol. 2000 Oct; 279(4):G726-32.; 
    PubMed
  66. Substance P is a determinant of lethality in diet-induced hemorrhagic pancreatitis in mice.
    Maa J, Grady EF, Yoshimi SK, Drasin TE, Kim EH, Hutter MM, Bunnett NW, Kirkwood KS
    Surgery. 2000 Aug; 128(2):232-9.; 
    PubMed
  67. Substance P mediates inflammatory oedema in acute pancreatitis via activation of the neurokinin-1 receptor in rats and mice.
    Grady EF, Yoshimi SK, Maa J, Valeroso D, Vartanian RK, Rahim S, Kim EH, Gerard C, Gerard N, Bunnett NW, Kirkwood KS
    Br J Pharmacol. 2000 Jun; 130(3):505-12.; 
    PubMed
  68. Substance P inhibits pancreatic exocrine secretion via a neural mechanism.
    Kirkwood KS, Kim EH, He XD, Calaustro EQ, Domush C, Yoshimi SK, Grady EF, Maa J, Bunnett NW, Debas HT
    Am J Physiol. 1999 08; 277(2):G314-20.; 
    PubMed
  69. Recent advances. General surgery.
    Corvera CU, Kirkwood KS
    BMJ. 1997 Sep 06; 315(7108):586-9.; 
    PubMed
  70. Prognostic indicators for cancer. Gastric cancer.
    Kirkwood KS, Khitin LM, Barwick KW
    Surg Oncol Clin N Am. 1997 Jul; 6(3):495-514.; 
    PubMed
  71. Substance P and bradykinin stimulate plasma extravasation in the mouse gastrointestinal tract and pancreas.
    Figini M, Emanueli C, Grady EF, Kirkwood K, Payan DG, Ansel J, Gerard C, Geppetti P, Bunnett N
    Am J Physiol. 1997 Apr; 272(4 Pt 1):G785-93.; 
    PubMed
  72. Neuroendocrine tumors: common presentations of uncommon diseases.
    Kirkwood KS, Debas HT
    Compr Ther. 1995 Dec; 21(12):719-25.; 
    PubMed